Multiple Assemblies exist for SMTL entry 5dry
Crystal structure of Dot1L in complex with inhibitor CPD3 [N-(1-(2-chlorophenyl)-1H-indol-6-yl)-2-(2-(5-(2-chlorophenyl)-1H-tetrazol-1-yl)acetyl)hydrazinecarboxamide]; X-RAY DIFFRACTION 2.41 Å

	SMTL ID 5dry.1 Ligands POTASSIUM ION; N-[1-(2-chlorophenyl)-1H-indol-6-yl]-2-{[5-(2-chlorophenyl)-1H-tetrazol-1-yl]acetyl}hydrazinecarboxamide Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer
	SMTL ID 5dry.2 Ligands POTASSIUM ION; N-[1-(2-chlorophenyl)-1H-indol-6-yl]-2-{[5-(2-chlorophenyl)-1H-tetrazol-1-yl]acetyl}hydrazinecarboxamide Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer